Evidence map›Paper›PMID 41077663›Full record

ArticleActa paediatrica (Oslo, Norway : 1992)2026

Low ICU Admission and Excellent Outcomes in MIS-C: A Swedish Study From an Open Society.

Petra Król, Maria Altman, Stefan Berg, Lillemor Berntson, Petter Brodin, Anders Fasth, Robin Kahn, Jenny Lingman Framme, Maria Mossberg, Charlotta Nordenhäll and 4 more

Abstract read
In one paragraph

Article in Acta paediatrica (Oslo, Norway : 1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Petra KrólDepartment of Paediatrics, Institute of Clinical Sciences Lund, Lund University, Lund, Sweden.
Maria AltmanDepartment of Paediatric Rheumatology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Stefan BergPaediatric Rheumatology, Queen Silvia Children's Hospital, Gothenburg, Sweden.
Lillemor BerntsonDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Petter BrodinDepartment of Women's and Children's Health, Karolinska Institute, Solna, Sweden.
Anders FasthPaediatric Rheumatology, Queen Silvia Children's Hospital, Gothenburg, Sweden.
Robin KahnDepartment of Paediatrics, Institute of Clinical Sciences Lund, Lund University, Lund, Sweden.
Jenny Lingman FrammeDepartment of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Maria MossbergDepartment of Paediatrics, Institute of Clinical Sciences Lund, Lund University, Lund, Sweden.
Charlotta NordenhällSachs' Children's Hospital, Stockholm, Sweden.
Karin PalmbladDepartment of Paediatric Rheumatology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
André RudolphDepartment of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Eva Säve-SöderberghPaediatric Clinic, Sunderby Hospital, Luleå, Sweden.
AnnaCarin HorneDepartment of Paediatric Rheumatology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.

Funding

Grants provided by Region Stockholm (ALF project)ReumatikerförbundetThe Greta and Johan Kocks FoundationThe Swedish governmental funding of clinical research (ALF)
6 · The paper itself

Abstract

aimDuring the COVID-19 pandemic, Sweden chose a more open public health approach. A general concern was that this approach would affect the population negatively. We describe the Swedish national MIS-C cohort and risk factors for severe disease defined as admission to the intensive care unit and cardiogenic shock.

methodsNationwide population-based cross-sectional study. All children and adolescents from 0 to 19 years of age with MIS-C from March 2020 to August 2022 were included. Multivariable logistic regression with ICU admission and cardiogenic shock as outcomes was used to evaluate risk factors for severe disease.

resultsA total of 338 MIS-C cases were identified; 69 patients (20%) required intensive care and 38 patients (11%) developed cardiogenic shock. Clinical findings associated with ICU admission were cardiac involvement: OR 14.00 (6.28-34.70), airway involvement: OR 6.75 (3.23-14.80), hyperinflammation: OR 3.25 (1.34-7.97), oedema: OR 2.40 (1.07-5.44) and diarrhoea: OR 2.23 (1.07-4.80). Clinical findings associated with cardiogenic shock were hyperinflammation: OR 5.10 (2.16-12.00), airway involvement: OR 4.87 (2.12-12.00), higher age (13-19 vs. 0-5 years): OR 3.85 (1.17-15.60), obesity: OR 3.55 (1.14-10.5) and diarrhoea: OR 2.48 (1.09-5.92).

conclusionIn Swedish national MIS-C cohort, the rate of ICU admission was low and outcome excellent. Identifying risk factors for ICU admission and cardiogenic shock may facilitate early detection of risk patients.

Indexed as

COVID-19Intensive Care UnitsShock, CardiogenicAdolescentChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantInfant, NewbornMaleRisk FactorsSwedenYoung AdultCOVID‐19MIS‐Crisk factorsseveritySweden

Identifiers

PMID41077663
PMCPMC12794792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.